NVO

Novo Nordisk

Exchange: NYSESector: HealthcareIndustry: Biotechnology

Values in USD · ADR · Reports in DKK

Novo Nordisk is a leading global health care company that's been making innovative medicines to help people with diabetes lead longer, healthier lives for more than 100 years. This heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, rare blood, and endocrine disorders. We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term, and do business in a financially, socially, and environmentally responsible way.

Current Price

—

GoodMoat Value

$87.03

Profile

Valuation (TTM)

Market Cap—

P/E—

EV—

P/B—

Shares Out—

P/Sales—

Revenue—

EV/EBITDA—

Novo Nordisk (NVO) Dividends

Dividend Overview

Dividend Yield

—

Dividend / Share

—

Key Metrics

Market Cap

—

P/E Ratio

—

Forward P/E

—

EPS

—

PEG Ratio

—

Book Value

—

Dividend Yield

—

Profit Margin

—

ROE

—

Dividend History

Dividend Safety

NVO Dividend Analysis

Novo Nordisk (NVO) dividend analysis including yield, payout history, and sustainability metrics.

This page shows Novo Nordisk's dividend overview, key metrics, historical payout data, and dividend safety assessment to help income-focused investors evaluate the sustainability of dividend payments.

GoodMoat's dividend analyzer evaluates payout ratios, earnings coverage, and free cash flow coverage to determine how well supported Novo Nordisk's dividend payments are. Use this analysis alongside the company's financial statements and quality score to make informed income-investing decisions.